Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. KEGG DRUG DrugBank Drug (Description in trials) KEGG GENES KEGG PATHWAY Disease ID
1 Afamelanotide 💬[1] Afamelanotide[1] Afamelanotide[1] MC1R 💬 [3] Hormone signaling, Melanogenesis, Neuroactive ligand-receptor interaction 💬[2] 159, 254 💬
2 Afamelanotide acetate 💬[1] Afamelanotide[1] AFAMELANOTIDE[1] MC1R 💬 [3] Hormone signaling, Melanogenesis, Neuroactive ligand-receptor interaction 💬[2] 159, 254 💬
3 Ipilimumab 💬[1] Ipilimumab[1] Ipilimumab[1] CTLA4 💬 [4] Autoimmune thyroid disease, Cell adhesion molecule (CAM) interaction, Rheumatoid arthritis, T cell receptor signaling pathway 💬[9] 13, 46, 49, 50, 51, 53, 96, 97, 159 💬
4 Isotretinoin 💬[1] Isotretinoin[1] Isotretinoin[2] RARA,
RARB 💬 		[8] Acute myeloid leukemia, Estrogen signaling pathway, Gastric cancer, Non-small cell lung cancer, Pathways in cancer, Small cell lung cancer, Th17 cell differentiation, Transcriptional misregulation in cancer 💬[4] 36, 39, 159, 160 💬
5 Melatonin 💬[1] Melatonin[1] Melatonin[2] MTNR1A,
MTNR1B 💬 		[2] Circadian entrainment, Neuroactive ligand-receptor interaction 💬[18] 2, 6, 8, 13, 37, 46, 49, 72, 78, 86, 90, 96, 97, 145, 149, 159, 202, 265 💬
6 Nivolumab 💬[1] Nivolumab[1] Nivolumab[1] PDCD1 💬 [3] Cell adhesion molecule (CAM) interaction, PD-L1 expression and PD-1 checkpoint pathway in cancer, T cell receptor signaling pathway 💬[12] 13, 26, 41, 46, 49, 50, 51, 53, 85, 96, 97, 159 💬